Results of a pivotal phase II study of brentuximab vedotin for patients with relapsed or refractory Hodgkin's lymphoma (Q36822162)
Jump to navigation
Jump to search
scientific article published on 26 March 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Results of a pivotal phase II study of brentuximab vedotin for patients with relapsed or refractory Hodgkin's lymphoma |
scientific article published on 26 March 2012 |
Statements
1 reference
Results of a pivotal phase II study of brentuximab vedotin for patients with relapsed or refractory Hodgkin's lymphoma (English)
1 reference
Joseph M Connors
1 reference
Nancy L Bartlett
1 reference
Bruce D Cheson
1 reference
Anas Younes
1 reference
Ajay K Gopal
1 reference
Scott E Smith
1 reference
Stephen M Ansell
1 reference
Joseph D Rosenblatt
1 reference
Kerry J Savage
1 reference
Radhakrishnan Ramchandren
1 reference
Sven de Vos
1 reference
Andres Forero-Torres
1 reference
Craig H Moskowitz
1 reference
Andreas Engert
1 reference
Emily K Larsen
1 reference
Dana A Kennedy
1 reference
Eric L Sievers
1 reference
Robert Chen
1 reference
1 reference
1 reference
Identifiers
1 reference